{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:51:47Z","timestamp":1792227107384,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000381","name":"UK Multiple Sclerosis Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000381","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jocn.2014.02.026","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T12:50:19Z","timestamp":1405083019000},"page":"2065-2071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Clinically isolated syndromes and the relationship to multiple sclerosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Wallace J.","family":"Brownlee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2014.02.026_b0005","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2014.02.026_b0010","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.02.026_b0015","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis","volume":"131","author":"Fisniku","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.02.026_b0020","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/jnnp.2006.090910","article-title":"Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? a global comparison","volume":"77","author":"Swanton","year":"2006","journal-title":"J Neurol Neurosurg Psych"},{"key":"10.1016\/j.jocn.2014.02.026_b0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1191\/1352458503ms914oa","article-title":"Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis","volume":"9","author":"Eriksson","year":"2003","journal-title":"Mult Scl"},{"key":"10.1016\/j.jocn.2014.02.026_b0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMcp053247","article-title":"Optic neuritis","volume":"354","author":"Balcer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2014.02.026_b0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archneur.1973.00490220060009","article-title":"Acute transverse myelopathy in adults. A follow-up study","volume":"28","author":"Lipton","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0045","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrneurol.2009.158","article-title":"Pediatric multiple sclerosis","volume":"5","author":"Yeh","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0050","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1212\/01.wnl.0000259422.44235.a8","article-title":"Consensus definitions proposed for pediatric multiple sclerosis and related disorders","volume":"68","author":"Krupp","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0055","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000338630.20412.45","article-title":"Role of MRI in the differentiation of ADEM from MS in children","volume":"72","author":"Callen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1001\/archophthalmol.2007.26","article-title":"Clinical course of optic neuritis in patients with relapsing neuromyelitis optica","volume":"126","author":"Papais-Alvarenga","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jocn.2014.02.026_b0070","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.0b013e31822c61b1","article-title":"AQP4 antibody-positive Thai cases: clinical features and diagnostic problems","volume":"77","author":"Siritho","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0075","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1212\/WNL.0b013e3182563b32","article-title":"Value of NMO-IgG determination at the time of presentation as CIS","volume":"78","author":"Costa","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0080","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1212\/01.wnl.0000237354.10144.ec","article-title":"Baseline MRI predicts future attacks and disability in clinically isolated syndromes","volume":"67","author":"Tintor\u00e9","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0085","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0090","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00415-007-0733-2","article-title":"Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b","volume":"255","author":"Polman","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0095","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00415-009-5063-0","article-title":"Clinical predictors of early second event in patients with clinically isolated syndrome","volume":"256","author":"Mowry","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0100","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/1352458511426740","article-title":"The effect of gender in clinically isolated syndrome (CIS): a meta-analysis","volume":"18","author":"Dobson","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.02.026_b0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.20363","article-title":"Is optic neuritis more benign than other first attacks in multiple sclerosis?","volume":"57","author":"Tintor\u00e9","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0110","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial","volume":"121","author":"Beck","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jocn.2014.02.026_b0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/1352458506071196","article-title":"Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis","volume":"13","author":"Feuillet","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.02.026_b0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1352458509350311","article-title":"Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes","volume":"16","author":"Zipoli","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.02.026_b0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/brain\/116.1.135","article-title":"The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis: A 5-year follow-up study","volume":"116","author":"Morrissey","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.02.026_b0130","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0002-9394(00)00761-3","article-title":"Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS","volume":"130","author":"Hauser","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jocn.2014.02.026_b0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1352458513494959","article-title":"Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes","volume":"20","author":"Martinelli","year":"2014","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.02.026_b0140","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/1352458508093679","article-title":"Smoking is a risk factor for early conversion to clinically definite multiple sclerosis","volume":"14","author":"Di Pauli","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.02.026_b0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1191\/1352458505ms1135oa","article-title":"Multiple sclerosis diagnostic criteria: three years later","volume":"11","author":"Polman","year":"2005","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.02.026_b0155","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0160","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/1352458509353650","article-title":"Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis","volume":"16","author":"Swanton","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.02.026_b0170","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.0b013e3181cec45c","article-title":"MRI criteria for MS in patients with clinically isolated syndromes","volume":"74","author":"Montalban","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0175","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis","volume":"120","author":"Barkhof","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.02.026_b0180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp.64.3.353","article-title":"Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination","volume":"64","author":"O\u2019Riordan","year":"1998","journal-title":"J Neurol Neurosurg Psych"},{"key":"10.1016\/j.jocn.2014.02.026_b0185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e31827b1a67","article-title":"Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis","volume":"80","author":"Sombekke","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.0b013e318220abd4","article-title":"The predictive value of gray matter atrophy in clinically isolated syndromes","volume":"77","author":"Calabrese","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0195","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1212\/WNL.0b013e3181ff96f6","article-title":"Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis","volume":"75","author":"Filippi","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0200","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/brain\/awh153","article-title":"Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis","volume":"127","author":"Fernando","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.02.026_b0205","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1093\/brain\/awh654","article-title":"Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis","volume":"128","author":"Fernando","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.02.026_b0210","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","article-title":"Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude","volume":"84","author":"Dobson","year":"2013","journal-title":"J Neurol Neurosurg Psych"},{"key":"10.1016\/j.jocn.2014.02.026_b0215","first-page":"885","article-title":"The predictive value of CSF oligoclonal banding for MS 5 years after optic neuritis","volume":"51","author":"Cole","year":"1998","journal-title":"Optic Neuritis Study Group. Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0220","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis","volume":"133","author":"Comabella","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.02.026_b0225","doi-asserted-by":"crossref","first-page":"e11986","DOI":"10.1371\/journal.pone.0011986","article-title":"The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS)","volume":"5","author":"Brettschneider","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jocn.2014.02.026_b0230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1191\/135248506ms1263oa","article-title":"Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis","volume":"12","author":"Brettschneider","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2014.02.026_b0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jnnp-2012-304333","article-title":"Onset of secondary progressive phase and long-term evolution of multiple sclerosis","volume":"85","author":"Scalfari","year":"2014","journal-title":"J Neurol Neurosurg Psych"},{"key":"10.1016\/j.jocn.2014.02.026_b0240","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/brain\/awg081","article-title":"Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process","volume":"126","author":"Confavreux","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.02.026_b0245","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1212\/WNL.0b013e3181feb26f","article-title":"Brainstem lesions in clinically isolated syndromes","volume":"75","author":"Tintor\u00e9","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0250","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/01.wnl.0000341935.41852.82","article-title":"Early MRI in optic neuritis: the risk for disability","volume":"72","author":"Swanton","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0255","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis","volume":"326","author":"Beck","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2014.02.026_b0260","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":"A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0265","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group","volume":"343","author":"Jacobs","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2014.02.026_b0270","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2014.02.026_b0275","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2014.02.026_b0280","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(11)70262-9","article-title":"Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial","volume":"11","author":"Comi","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0285","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","article-title":"Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Comi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2014.02.026_b0290","first-page":"8","volume":"19","author":"Miller","year":"2013","journal-title":"TOPIC main outcomes: efficacy and safety of once-daily oral teriflunomide in patients with clinically isolated syndrome Mult Scler."},{"key":"10.1016\/j.jocn.2014.02.026_b0295","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(07)61194-5","article-title":"Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study","volume":"370","author":"Kappos","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2014.02.026_b0300","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(09)70237-6","article-title":"Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial","volume":"8","author":"Kappos","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0305","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13760-012-0166-2","article-title":"Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial","volume":"113","author":"Derakhshandi","year":"2013","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.jocn.2014.02.026_b0310","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/jnnp.2010.208660","article-title":"MRI only conversion to multiple sclerosis following a clinically isolated syndrome","volume":"82","author":"Chard","year":"2011","journal-title":"J Neurol Neurosurg Psych"},{"key":"10.1016\/j.jocn.2014.02.026_b0315","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/jnnp-2013-306573.191","article-title":"Most neurologists in Scotland do not use the McDonald criteria to diagnose multiple sclerosis","volume":"84","author":"Lumley","year":"2013","journal-title":"J Neurol Neurosurg Psych"},{"key":"10.1016\/j.jocn.2014.02.026_b0320","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2014.02.026_b0325","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/brain\/awq146","article-title":"A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials","volume":"133","author":"Henderson","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2014.02.026_b0330","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.msard.2013.02.001","article-title":"Neuroprotection for acute optic neuritis \u2014 can it work?","volume":"2","author":"Raftopoulos","year":"2013","journal-title":"Mult Scler Related Dis"},{"key":"10.1016\/j.jocn.2014.02.026_b0335","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrneurol.2012.200","article-title":"Neuroprotection and repair in multiple sclerosis","volume":"8","author":"Franklin","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2014.02.026_b0340","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm1664","article-title":"LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis","volume":"13","author":"Mi","year":"2007","journal-title":"Nature Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814002732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814002732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T17:26:16Z","timestamp":1538414776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586814002732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0967586814002732"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2014.02.026","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically isolated syndromes and the relationship to multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2014.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}